Where CBC comes from
Every major cannabinoid in hemp starts as CBGA, cannabigerolic acid. The plant makes CBGA first and then routes it down one of three enzymatic paths. THCA synthase turns it into THCA. CBDA synthase turns it into CBDA. CBCA synthase turns it into CBCA, which loses a carbon dioxide molecule with heat or time and becomes CBC.
Which path dominates is genetic. A hemp cultivar bred for CBD carries a lot of CBDA synthase, so most of its CBGA goes that way. Whatever the plant does not route to CBDA still gets divided, and CBC is where a meaningful share of the remainder lands. In many CBD-dominant cultivars CBC sits somewhere between 0.1% and 0.5% of dry weight, which is small in absolute terms and large relative to every other minor cannabinoid.
Why CBC is not sold on its own
Two reasons, both economic.
Isolating CBC is difficult. It has a boiling point and polarity close enough to several other cannabinoids that separating it cleanly takes more chromatography than separating CBD or CBG does. The yield per pound of biomass is low and the process cost is high.
The second reason is that there is no consumer demand pulling it off the shelf. CBN has a sleep story, CBG has a focus story, and CBC has no simple one-line pitch that a shopper already recognizes. Brands respond to that by folding CBC into full-spectrum blends and not naming it. If you own a full-spectrum tincture, CBC is in it, and the COA will show you how much.
How CBC works, and why it is unusual
CBC has poor affinity for CB1, which is why it is non-intoxicating. It has some affinity for CB2. Neither of those is where most of the interest sits.
CBC is a strong agonist at TRPA1 and it acts on TRPV1. These are transient receptor potential channels, the sensory ion channels that respond to temperature and to irritants. TRPV1 is the receptor capsaicin binds, which is why chili peppers feel hot. TRPA1 responds to mustard oil, cinnamon and horseradish. Ethan Russo and colleagues have argued this TRP channel activity is where several minor cannabinoids do their work, rather than at CB1 or CB2 at all.
CBC also appears to slow the reuptake of anandamide, which would leave more of your own endocannabinoid in circulation. That is the same broad mechanism proposed for CBD, arrived at by a different route.
Most of this comes from cell and animal work. Human clinical trials on isolated CBC are close to nonexistent, and anyone telling you what CBC does in people is extrapolating.
CBC and light
CBC converts to CBL, cannabicyclol, on exposure to ultraviolet light. The reaction is one-way. CBL does not convert back.
This is a practical storage point rather than a curiosity. A full-spectrum oil in a clear bottle on a sunny windowsill loses CBC faster than the same oil in amber glass in a cupboard. It is one of several reasons hemp extracts ship in dark bottles, and one of the reasons a COA dated eighteen months ago does not necessarily describe what is in the bottle today.
How to find out if you are getting any
Read the certificate of analysis. Most full-panel COAs test for ten or more cannabinoids, and CBC is usually on the list. Look for a number in the tenths of a percent, or a milligram figure per container.
If the COA only lists CBD, delta-9 THC and total THC, that is a potency panel rather than a full cannabinoid panel, and it cannot tell you anything about CBC. A broad-spectrum or isolate product will show CBC at non-detect, because the processing that strips THC strips most minor cannabinoids alongside it.
